The National Institute for Occupational Safety and Health (NIOSH) received a request for a health hazard evaluation from the management of the University Medical Center in Las Vegas, Nevada. The document summarizes NIOSH's evaluation and recommendations concerning potential healthcare personnel exposures to cisplatin during a mock interperitoneal procedure.